SFCL
REGN icon

Strengthening Families & Communities LLC’s Regeneron Pharmaceuticals REGN Stock Holding History

Strengthening Families & Communities LLC’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.7K Buy
25
+1
+4% +$681 ﹤0.01% 316
2026
Q1 		$18.7K Sell
24
-1
-4% -$766 ﹤0.01% 280
2025
Q4 		$19.4K Sell
25
-8
-24% -$5.43K 0.01% 191
2025
Q3 		$18.6K Hold
33
– – ﹤0.01% 322
2025
Q2 		$17.4K Sell
33
-3
-8% -$1.67K 0.01% 201
2025
Q1 		$22.9K Hold
36
– – 0.01% 195
2024
Q4 		$26K Hold
36
– – 0.01% 187
2024
Q3 		$37.8K Hold
36
– – 0.01% 264
2024
Q2 		$38K Buy
36
+1
+3% +$969 0.01% 277
2024
Q1 		$34K Hold
35
– – 0.02% 125
2023
Q4 		$30.7K Hold
35
– – 0.02% 129
2023
Q3 		$29K Hold
35
– – 0.01% 255
2023
Q2 		$25K Buy
+35
New +$27K 0.01% 285
2022
Q4 		$18K Hold
25
– – 0.01% 188
2022
Q3 		$17K Hold
25
– – 0.01% 288
2022
Q2 		$17K Hold
25
– – 0.01% 193
2022
Q1 		$17K Hold
25
– – 0.01% 192
2021
Q4 		$16K Buy
+25
New +$15.4K ﹤0.01% 180

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Strengthening Families & Communities LLC's REGN Position: Q2 2026 in Review

Strengthening Families & Communities LLC increased its Regeneron Pharmaceuticals (REGN) stake by 4.2% in Q2 2026, buying an estimated $681 and bringing the position to 25 shares worth $15.7K. The position accounts for ﹤0.01% of the portfolio, ranked #316.

Strengthening Families & Communities LLC first reported a position in REGN in Q4 2021 and has held it in 18 quarters since. The position peaked at $38K in Q2 2024. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Strengthening Families & Communities LLC held 25 shares of Regeneron Pharmaceuticals worth $15.7K as of Q2 2026.
  • Strengthening Families & Communities LLC bought 1 Regeneron Pharmaceuticals share in Q2 2026, an estimated $681.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Strengthening Families & Communities LLC's portfolio in Q2 2026, its #316 holding.
  • Strengthening Families & Communities LLC first reported a position in Regeneron Pharmaceuticals in Q4 2021 and has held it in 18 quarters since.
  • Strengthening Families & Communities LLC's Regeneron Pharmaceuticals position peaked at $38K in Q2 2024.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Strengthening Families & Communities LLC's 13F filing for Q2 2026, filed 11 Aug 2026.